Chitin/PLGA blend microspheres as a biodegradable drug-delivery system: phase-separation, degradation and release behavior

被引:108
作者
Mi, FL
Lin, YM
Wu, YB
Shyu, SS [1 ]
Tsai, YH
机构
[1] Natl Cent Univ, Dept Chem Engn, Chungli 320, Taiwan
[2] Kaohsiung Med Univ, Dept Pharm, Kaohsiung 820, Taiwan
[3] Chinese Naval Acad, Dept Appl Sci, Div Appl Chem, Kaohsiung 813, Taiwan
关键词
chitin; PLGA; 50/50; biodegradable; microsphere; phase separation; drug delivery;
D O I
10.1016/S0142-9612(02)00084-4
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
A novel chitin-based microsphere was developed for anti-cancer drug-delivery purpose in the present study. These biodegradable microspheres were prepared by directly blending chitin with different contents of poly(D,L-lactide-co-glycolide 50:50) (PLGA 50/50) in dimethylacetamide-lithium chloride solution, and following it by coagulating in water via wet phase inversion. Scanning electron microscopy (SEM) micrography of the blend microsphere showed that there are numerous PLGA particulates homogeneously dispersed in chitin matrix, suggesting the occurrence of obvious phase separation from the blended chitin and PLGA 50/50 phase due to their thermodynamic incompatibility. Degradation of the chitin/PLGA 50/50 blend microsphere depends on the Surface erosion of chitin phase and bulk hydrolysis of PLGA phase, according to the examinations of SEM and differential scanning calorimetry studies. Weight loss of the chitin/PLGA 50/50 blend microsphere increases with the increase of chitin content in the microsphere. A two-phase drug-release model is observed from the release of chlorambucil from chitin/PLGA 50/50 blend microspheres. The initial stage of drug-release rate increases with the increased chitin content due to the hydration and surface erosion of hydrophilic chitin phase; however, the following stage of slow release is sustained for several days, mainly contributed by the bulk hydrolysis of hydrophobic PLGA phase. In conclusion, Such a chitin/PLGA 50150 blend microsphere is novel and interesting, and may be used as a special drug-delivery system. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:3257 / 3267
页数:11
相关论文
共 21 条
[1]   Delivering neuroactive molecules from biodegradable microspheres for application in central nervous system disorders [J].
Cao, XD ;
Shoichet, MS .
BIOMATERIALS, 1999, 20 (04) :329-339
[2]   Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles [J].
Dunne, M ;
Corrigan, OI ;
Ramtoola, Z .
BIOMATERIALS, 2000, 21 (16) :1659-1668
[3]  
Eliaz RE, 2000, J BIOMED MATER RES, V50, P388, DOI 10.1002/(SICI)1097-4636(20000605)50:3<388::AID-JBM13>3.3.CO
[4]  
2-6
[5]   In vitro degradation of a novel poly(lactide-co-glycolide) 75/25 foam [J].
Holy, CE ;
Dang, SM ;
Davies, JE ;
Shoichet, MS .
BIOMATERIALS, 1999, 20 (13) :1177-1185
[6]   Novel polyphosphazene/poly(lactide-co-glycolide) blends:: miscibility and degradation studies [J].
Ibim, SEM ;
Ambrosio, AMA ;
Kwon, MS ;
El-Amin, SF ;
Allcock, HR ;
Laurencin, CT .
BIOMATERIALS, 1997, 18 (23) :1565-1569
[7]   The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices [J].
Jain, RA .
BIOMATERIALS, 2000, 21 (23) :2475-2490
[8]   POLYMERS FOR SUSTAINED-RELEASE OF PROTEINS AND OTHER MACROMOLECULES [J].
LANGER, R ;
FOLKMAN, J .
NATURE, 1976, 263 (5580) :797-800
[9]   In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams [J].
Lu, L ;
Peter, SJ ;
Lyman, MD ;
Lai, HL ;
Leite, SM ;
Tamada, JA ;
Uyama, S ;
Vacanti, JP ;
Langer, R ;
Mikos, AG .
BIOMATERIALS, 2000, 21 (18) :1837-1845
[10]  
Lu L, 1999, J BIOMED MATER RES, V46, P236, DOI 10.1002/(SICI)1097-4636(199908)46:2<236::AID-JBM13>3.0.CO